PDS Biotechnology (PDSB) Tops Q1 EPS by 2c

PDS Biotechnology (NASDAQ: PDSB) reported Q1 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
• Bernstein SocGen Group Upgrades Sona BLW Precision (SONACOMS:IN) to Outperform
• NB Bancorp, Inc. (NBBK) Tops Q2 EPS by 14c